Pronova Biopharma Norge as v. Teva Pharmaceuticals Usa, Inc.

U.S. Court of Appeals for the Federal Circuit

Pronova Biopharma Norge as v. Teva Pharmaceuticals Usa, Inc.

Opinion

Case: 12-1498 Document: 47 Page: 1 Filed: 12/27/2012

NOTE: This order is nonprecedential.

United States Court of Appeals for the Federal Circuit __________________________

PRONOVA BIOPHARMA NORGE AS, Plaintiff-Appellee,

v. TEVA PHARMACEUTICALS USA, INC., Defendant-Appellant,

AND

PAR PHARMACEUTICAL, INC. AND PAR PHARMACEUTICAL COMPANIES, INC., Defendants-Appellants. __________________________

2012-1498, -1499 __________________________

Appeals from the United States District Court for the District of Delaware in consolidated case nos. 09-CV-0286 and 09-CV-0305, Judge Sue L. Robinson. __________________________

ON MOTION __________________________

ORDER

Teva Pharmaceuticals USA, Inc. (“Teva”) and Par Pharmaceutical Companies, Inc. (collectively “Par”) Case: 12-1498 Document: 47 Page: 2 Filed: 12/27/2012

PRONOVA BIOPHARMA NORGE V. TEVA PHARMACEUTICALS 2

jointly move for an extension of time, until January 16, 2013 to file their reply briefs.

Upon consideration thereof,

IT IS ORDERED THAT:

(1) The December 19, 2012 motion is granted. (2) The December 13, 2012 motion is withdrawn.

FOR THE COURT

/s/ Jan Horbaly Jan Horbaly Clerk s27

Reference

Status
Unpublished